Eisai

Q: What industry does Eisai belong to?

Eisai is in the industry of: Pharmaceuticals , Healthcare

Q: What is Eisai competition?

Eisai top competitors include: Bristol-Myers Squibb Co , Amneal Pharmaceuticals Inc , H Lundbeck A/S , Biogen

Manufacturing · Japan · 11,322 Employees

Headquartered in Tokyo, Japan, Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products.Read More

View Company Info for Free

Who is Eisai

Headquarters

4-6-10 Koishikawa Bunkyo-ku, Tokyo, Tokyo, 112-8088, Japan

Phone Number

+81 338173700

Website

www.eisai.com

Revenue

$5.3B

Industry

Pharmaceuticals

Healthcare

Is this data correct?

View contact profiles from Eisai

Popular SearchesEisai Co. LtdEisai Co LtdEisai Corporation Of North AmericaEisai Inactive PageEisai IncSIC Code 28,283NAICS Code 32,325Show More

Top Competitors of Eisai

Bristol-Myers Squibb Co
34,300
$46.2B
1
Amneal Pharmaceuticals Inc
7,600
$2.2B
2
H Lundbeck A/S
5,400
$2.3B
3
Biogen
9,090
$10.2B
4
Astellas Pharma Inc
14,522
$10.9B
5
Alexion Pharmaceuticals Inc
4,000
$6.1B
6

Eisai Org Chart

Haruo Naito

Director, Representative Cor...

Phone

Yasushi Okada

Representative Corporate Off...

Phone

Ryohei Yanagi

Executive VP & Chief Financi...

Phone

Eisai Email Formats

Eisai uses at least 5 email formats with first_last (ex. John_Smith@eisai.com) being used 31.7% of the time

Eisai Email Formats		Percentage
first_last	John_Smith@eisai.com	31.7%
first initials + middle initials + last	JLSmith@hhc.eisai.co.jp	29.8%
first.last	John.Smith@hhc.eisai.co.jp	0%
first + last	JohnSmith@hhc.eisai.co.jp	0%
first	John@hhc.eisai.co.jp	0%

Get Verified Emails

View Email Formats for Eisai

Eisai Company Metrics

Company Insights

Employee Growth Rate

Acquisitions & Subsidiaries

Jul 18, 2022

Eisai

Dec 17, 2021

KAN Research Institute, Inc.

Apr 10, 2021

Arteryex

Guilford Pharmaceuticals

Gliatech

proquestpharm.com

See More Acquisitions & Subsidiaries

Eisai Tech Stack

Swoogo

HashiCorp Terraform

Terraform

Microsoft Dynamics GP

Microsoft

Microsoft Dynamics

Microsoft

See more technologies

Eisai News & Media

Eisai's Sales Subsidiary Collaborates with Ministry of Public Health (MOPH) in Thailand
TOKYO, Nov 30, 2023 - (JCN Newswire) - Eisai Co., Ltd. announced today that its Thai sales subsidiary Eisai (Thailand) Marketing Co., Ltd., (Eisai Thailand) has made an agreement to collaborate with the Department of Medical Services (DMS), Ministry of Public Health (MOPH) of Thailand to further enhance the access to treatments for dementia including Alzheimer’s disease (AD) in Thailand. In Thailand, the number of people suffering from dementia is expected to increase significantly from
Nov 30, 2023
www.jcnnewswire.com
Eisai to Present Latest Data on Perampanel at The 77th American Epilepsy Society (AES) Annual Meeting
TOKYO, Nov 22, 2023 - (JCN Newswire) - Eisai Co., Ltd. announced today that the company will have a total of nine poster presentations, including the latest data on its in-house discovered and developed anti-epileptic agent (AED) perampanel (product name: Fycompa) at the 77th American Epilepsy Society Annual Meeting (AES 2023), to be held in Orland, Florida and virtually from December 1-5, 2023. Major presentations include the design and outcomes of a clinical research evaluating
Nov 22, 2023
www.jcnnewswire.com
LEQEMBI Wins Best New Drug And Clinical Advance of The Year at The Scrip Awards 2023
TOKYO and CAMBRIDGE, Mass., Nov 20, 2023 - (JCN Newswire) - Eisai Co., Ltd. and Biogen Inc. (Nasdaq: BIIB) announced today that Alzheimer’s disease (AD) treatment LEQEMBI® (lecanemab-irmb) was awarded both the Best New Drug and Clinical Advance of the Year for the Phase III Clarity AD study at the Scrip Awards 2023, held by Citeline. The Scrip Awards, now in its 19th year, celebrates the best innovations and achievements of the international biopharma industry.
Nov 20, 2023
www.jcnnewswire.com
EISAI PRESENTS NEW LEQEMBI® (LECANEMAB-IRMB) INVESTIGATIONAL SUBCUTANEOUS FORMULATION INTERIM STUDY RESULTS AND CLINICAL IMPROVEMENT DATA IN EARLIER STAGES OF EARLY ALZHEIMER'S DISEASE FROM ADDITIONAL ANALYSES OF CLARITY AD AT THE CLINICAL TRIALS ON ALZHEIMER'S DISEASE (CTAD) CONFERENCE
INVESTIGATIONAL SUBCUTANEOUS FORMULATION CLEARS 14% MORE PLAQUE THAN IV, PHARMACOKINETICS (AUC) 11% HIGHER, AND SIMILAR ARIA RATES TO IV 76% OF PATIENTS SHOWED NO DECLINE AND 60% SHOWED CLINICAL IMPROVEMENT AT 18 MONTHS IN LOW-TAU SUBPOPULATION IN ADDITIONAL ANALYSIS OF CLARITY AD...
Oct 25, 2023
www.prnewswire.com
LEQEMBI® (lecanemab-irmb) NAMED ONE OF TIME's BEST INVENTIONS OF 2023
Recognized in the Medical Care Category NUTLEY, N.J., and CAMBRIDGE, Mass., Oct. 24, 2023 /PRNewswire/ -- Eisai Inc. and Biogen Inc. are honored to announce today that TIME has selected LEQEMBI® (lecanemab-irmb) as one of the Best Inventions of 2023 in the Medical Care category. LEQEMBI...
Oct 24, 2023
www.prnewswire.com

Frequently Asked Questions regarding Eisai

Where is Eisai located?

Eisai's headquarters are located at 4-6-10 Koishikawa Bunkyo-ku, Tokyo, Tokyo, 112-8088, Japan

What is Eisai's phone number?

Eisai's phone number is +81 338173700

What is Eisai's official website?

Eisai's official website is www.eisai.com

What is Eisai's Revenue?

Eisai's revenue is $5.3 Billion

What is Eisai's SIC code?

Eisai's SIC: 28,283

What is Eisai's NAICS code?

Eisai's NAICS: 32,325

How many employees does Eisai have?

Eisai has 11,322 employees

What industry does Eisai belong to?

Eisai is in the industry of: Pharmaceuticals, Healthcare

What is Eisai competition?

Eisai top competitors include: Bristol-Myers Squibb Co, Amneal Pharmaceuticals Inc, H Lundbeck A/S, Biogen

What companies has Eisai acquired?

Eisai has acquired the companies: Eisai, KAN Research Institute, Inc., Arteryex, Guilford Pharmaceuticals

What technology does Eisai use?

Some of the popular technologies that Eisai uses are: Swoogo, HashiCorp Terraform, Microsoft Dynamics GP, Microsoft Dynamics

Who is the CEO of Eisai?

Eisai's CEO is Haruo Naito

Who is the CFO of Eisai?

Eisai's CFO is Ryohei Yanagi

How do I contact Eisai?

Eisai contact info: Phone number: +81 338173700 Website: www.eisai.com

What does Eisai do?

Headquartered in Tokyo, Japan, Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products.... Read More

What are Eisai social media links?

Eisai Linkedin page Eisai Twitter page

Is Eisai a public company?

Eisai is private company therefore does not currently have an official ticker symbol

See more information about Eisai